CohBar to Present at the H.C. Wainwright 4th Annual NASH Investor Conference
MENLO PARK, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria […]
Tonix Pharmaceuticals Announces Plan to Complete the Phase 3 RELIEF Study of TNX-102 SL for Management of Fibromyalgia with Currently Enrolled Participants Based on Results of Interim Analysis
Topline Results of Full Study Expected Fourth Quarter 2020RELIEF Study Protocol Was Formally Amended Mid-Study to Conform to FDA Guidance […]
Prelude Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
WILMINGTON, Del., Sept. 29, 2020 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced […]
TRI Pointe Group, Inc. Announces Third Quarter 2020 Earnings Release and Conference Call Date
IRVINE, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) —TRI Pointe Group, Inc. (NYSE: TPH) announced today that it will release its […]
Micron Technology, Inc. Reports Results for the Fourth Quarter and Full Year of Fiscal 2020
DRAM portfolio strengthened with 1z ramp; High-value NAND shipments reach record levels in FY20Bay Street News
Verisk Elects General Vincent Brooks to Board of Directors
Jersey City, NJ, Sept. 29, 2020 (GLOBE NEWSWIRE) — Verisk (Nasdaq:VRSK), a leading data analytics provider, announces the addition of […]
FuelCell Energy Announces Launch of Offering of Common Stock
DANBURY, Conn., Sept. 29, 2020 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) (“FuelCell Energy” or the “Company”) today announced […]
Westell Stockholders Approve Reverse and Forward Splits
AURORA, Ill., Sept. 29, 2020 (GLOBE NEWSWIRE) — Westell Technologies, Inc. (NASDAQ: WSTL), a leading provider of high-performance network infrastructure […]
Rubius Therapeutics to Participate in 7th Annual Jefferies Cell Therapy Summit
CAMBRIDGE, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red […]
Jiayin Group Inc. Announces Closing of the Acquisition of 35% Equity Interest in Keen Best Investments Limited
SHANGHAI, China, Sept. 30, 2020 (GLOBE NEWSWIRE) — Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech […]
